Prelude Therapeutics Q1 EPS $(0.47)
Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.47) per share.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
